FDA reevaluating whether over-the-counter decongestant really works

(2:24)

FDA's Missed Opportunities to Tackle Endocrine Disrupting Chemicals in Food

(47:48)

FDA Plans To Re-evaluate The Term “Healthy”

(1:53)

ILSI NA: Food Packaging Safety: FDA Packaging Factors (Jessica Cooper)

(28:4)

FDA advisory committee says active ingredient in congestion relief drugs doesn't relieve congestion

(1:42)

FDA redefining definition of ‘healthy’

(22)

Decongestant ingredient deemed ineffective: FDA

(2:27)

FDA to re-evaluate COVID vaccine doses

(56)

FDA Review and Approval Process for Biosimilar Medications

(1:58)

What is FDA’s role in regulating drugs? (15 seconds)

(16)

Over-the-counter nasal decongestants don't work: FDA | Morning in America

(3:36)

Here's how the FDA might go about regulating CBD

(5:27)

Understanding FDA Inspections and Data

(1:56:15)

Nutrition News Updates \u0026 your questions (Q\u0026A)

(1:4:22)

Common over-the-counter decongestant does not work, FDA panel says

(3:37)

Meet the Bug You Didn't Know You Were Eating | Deep Look

(5:17)

FDA | NIH: Regulatory Do’s and Don'ts: Tips from FDA – CDER Segment

(1:16:43)

FDA Drug Manufacturing Inspections - REdI 2020

(52:33)

FDA Inspection and Audit Common Findings

(1:8:52)

FDA Clinical Investigator Training Course (CITC) 2024 (Day 3 of 3)

(4:7:45)

Why Does The FDA Exist?

(4:11)

FDA says some cold and allergy drugs have an ineffective key ingredient

(3:48)

Popular nasal decongestant doesn't actually relieve congestion, FDA advisers say

(56)

FDA approves use of ketamine-derived depression treatment

(1:51)

Your Guide to Reporting Problems to FDA (Consumer Update)

(3:)

FDA investigating possible increased risk of death with lymphoma medicine Ukoniq (umbralisib)

(3:31)

FDA advisers say oral form nasal decongestants are ineffective 

(2:13)

FDA panel determines popular decongestant doesn't work

(3:1econd)

FDA reevaluating safety of cough syrup for kids

(2:2)

RettEd: What Comes Next? The FDA Regulatory Process from NDA to FDA Decision and Beyond

(1:2:10)